A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: First-in-human trial of ChAd63-KH

Views
A ...1316

Total Visits Per Month

June 2024July 2024August 2024September 2024October 2024November 2024December 2024
A ...1732444923410

File Visits

Views
29FL5e9GFDkgQ.pdf434